IRadimed
IRMD
#5595
Rank
A$1.85 B
Marketcap
A$145.72
Share price
2.47%
Change (1 day)
74.32%
Change (1 year)
Categories

Earnings for IRadimed (IRMD)

Earnings in 2025 (TTM): A$41.9 Million

According to IRadimed's latest financial reports the company's current earnings are A$80.51 Million. In 2024 the company made an earning of A$36.71 Million, an increase over its 2023 earnings that were of A$32.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IRadimed from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$41.9 M14.12%
2024 A$36.71 M11.67%
2023 A$32.88 M34.35%
2022 A$24.47 M64.5%
2021 A$14.87 M-1694.53%
2020 -A$0.94 Million-106.82%
2019 A$13.67 M45.92%
2018 A$9.37 M343.81%
2017 A$2.11 M-87.25%
2016 A$16.56 M-5.86%
2015 A$17.59 M285.59%
2014 A$4.56 M8.39%
2013 A$4.21 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AtriCure
ATRC
-A$33.28 Million-181.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
A$92.15 M 126.36%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.47 B 3,533.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$2.58 B 6,242.24%๐Ÿ‡บ๐Ÿ‡ธ USA